Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Localized Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00828308
What this trial is testing

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 16
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Not applicableWithdrawnNCT03514927
What this trial is testing

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage I AJCC V6Prostate Cancer Stage IIProstate Cancer Stage III
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT03568188
What this trial is testing

Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 174
Early research (Phase 1)WithdrawnNCT00691977
What this trial is testing

Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate

Who this might be right for
Prostate Cancer
Virginia Commonwealth University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07300566
What this trial is testing

Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial

Who this might be right for
Prostate Cancer
Joelle Helou 58
Not applicableActive Not RecruitingNCT04349501
What this trial is testing

Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)

Who this might be right for
Prostate Cancer
University of California, San Diego 100
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Large-scale testing (Phase 3)Looking for participantsNCT03258320
What this trial is testing

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Who this might be right for
Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine 300
Large-scale testing (Phase 3)Ended earlyNCT05009290
What this trial is testing

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Who this might be right for
Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Jiangsu HengRui Medicine Co., Ltd. 391
Not applicableStudy completedNCT04853914
What this trial is testing

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Who this might be right for
Benign Prostatic Hyperplasia
EDAP TMS S.A. 9
Early research (Phase 1)Study completedNCT00030277
What this trial is testing

High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Focus Surgery 20
Testing effectiveness (Phase 2)Looking for participantsNCT06678126
What this trial is testing

Adaptive Versus Non-adaptive Radiotherapy and 2 Bladder Filling Instructions for Patients With Intermediate or High Risk Localized Prostate Cancer (ARP)

Who this might be right for
Prostate Cancer
Scott Tyldesley 104
Early research (Phase 1)Active Not RecruitingNCT06703437
What this trial is testing

Long Acting Neuraxial Peri-prostatic Block in Cancer

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 12
Testing effectiveness (Phase 2)WithdrawnNCT06218667
What this trial is testing

Copanlisib in Combination with Degarelix in People with Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT02296229
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage III Prostate Cancer
Jonsson Comprehensive Cancer Center 220
Not applicableLooking for participantsNCT06491056
What this trial is testing

Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

Who this might be right for
Prostate Cancer
Singapore General Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT04947254
What this trial is testing

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate CarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+4 more
M.D. Anderson Cancer Center 200
Not applicableLooking for participantsNCT07788625
What this trial is testing

¹⁸F-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Hong Kong 60
Next Page